{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:43:55Z","timestamp":1776512635899,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T00:00:00Z","timestamp":1514332800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1245\/s10434-017-6307-3","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T22:44:31Z","timestamp":1514414671000},"page":"679-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer"],"prefix":"10.1245","volume":"25","author":[{"given":"Tommaso","family":"Cornali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Sammartino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Kopanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Christopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuisa","family":"Framarino dei Malatesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Spagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Biacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Spiliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"6307_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin."},{"key":"6307_CR2","unstructured":"Ferlay J, Soerjomataram I, Erwik M, et al. International agency for research on cancer. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC CancerBase no. 11. http:\/\/globocan.iarc.fr. Accessed 20 Jun 2017."},{"key":"6307_CR3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2014.02.019","volume":"133","author":"SC Dowdy","year":"2014","unstructured":"Dowdy SC. Improving oncologic outcomes for women with endometrial cancer: realigning our sights. Gynecol Oncol. 2014;133:370\u20134.","journal-title":"Gynecol Oncol."},{"key":"6307_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2016.10.025","volume":"144","author":"S Bendifallah","year":"2017","unstructured":"Bendifallah S, Ouldamer L, Lavoue V, et al. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO consensus conference risk groups: results from the FRANCOGYN Study Group. Gynecol Oncol. 2017;144:107\u201312.","journal-title":"Gynecol Oncol."},{"key":"6307_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suronc.2016.11.001","volume":"26","author":"S Bendifallah","year":"2017","unstructured":"Bendifallah S, Perrin M, Ouldamer L, et al. Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion. Surg Oncol. 2017;26:1\u20137.","journal-title":"Surg Oncol."},{"key":"6307_CR6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","volume":"129","author":"TA Ayeni","year":"2013","unstructured":"Ayeni TA, Bakkum-Gamez JN, Mariani A, et al. Comparative outcomes assessment of uterine grade 3 endometrioid, serous and clear cell carcinomas. Gynecol Oncol. 2013;129:478\u201385.","journal-title":"Gynecol Oncol."},{"key":"6307_CR7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/IGC.0000000000000131","volume":"24","author":"HJ Huang","year":"2014","unstructured":"Huang HJ, Tang YH, Chou HH, et al. Treatment failure in endometrial carcinoma. Int J Gynecol Cancer. 2014;24:885\u201393.","journal-title":"Int J Gynecol Cancer."},{"key":"6307_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/14737140.2016.1190650","volume":"16","author":"V Zanfagnin","year":"2016","unstructured":"Zanfagnin V, Ferrero A, Biglia N, et al. The role of surgery in recurrent endometrial cancer. Expert Rev Anticancer Ther. 2016;16:741\u201350.","journal-title":"Expert Rev Anticancer Ther."},{"key":"6307_CR9","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1245\/s10434-015-4443-1","volume":"22","author":"WD Joo","year":"2015","unstructured":"Joo WD, Schwartz PE, Rutherford TJ, et al. Microscopic omental metastasis in clinical stage I endometrial cancer: a meta-analysis. Ann Surg Oncol. 2015;22:3695\u2013700.","journal-title":"Ann Surg Oncol."},{"key":"6307_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv158","author":"AS Felix","year":"2015","unstructured":"Felix AS, Brinton LA, McMeekin DS, et al. Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG Oncology\/Gynecologic Oncology Group 210 Trial. J Natl Cancer Inst. 2015. https:\/\/doi.org\/10.1093\/jnci\/djv158.","journal-title":"J Natl Cancer Inst."},{"key":"6307_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2013.04.013","volume":"130","author":"SA Milgrom","year":"2013","unstructured":"Milgrom SA, Kollmeier MA, Abu-Rustum NR, Makker V, Gardner GJ, Barakat RR, Alektiar KM. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecol Oncol. 2013;130:49\u201353.","journal-title":"Gynecol Oncol."},{"key":"6307_CR12","first-page":"529","volume":"36","author":"O Kraemer","year":"2015","unstructured":"Kraemer O, Rapiti E, Huber D, Lopes-Raimundo E, Usel M, Bouchardy C, Petignat P. Stage IVB endometrial cancer: clinical course and survival of patients with single and multiple metastases. Eur J Gynaecol Oncol. 2015;36:529\u201332.","journal-title":"Eur J Gynaecol Oncol."},{"key":"6307_CR13","first-page":"281","volume":"11","author":"Y Li","year":"2014","unstructured":"Li Y, Yu Y, Liu Y. Report on the 9(th) International Congress on peritoneal surface malignancies. Cancer Biol Med. 2014;11:281\u20134.","journal-title":"Cancer Biol Med."},{"key":"6307_CR14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1245\/s10434-017-5793-7","volume":"24","author":"PH Sugarbaker","year":"2017","unstructured":"Sugarbaker PH. The seven best from PSOGI 2016. Ann Surg Oncol. 2017;24:870\u20134.","journal-title":"Ann Surg Oncol."},{"key":"6307_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/02656736.2017.1301576","volume":"33","author":"D Go\u00e9r\u00e9","year":"2017","unstructured":"Go\u00e9r\u00e9 D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH, Glehen O. Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). Int J Hyperthermia. 2017;33:520\u20137.","journal-title":"Int J Hyperthermia."},{"key":"6307_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1525-1438.2006.00751.x","volume":"17","author":"CW Helm","year":"2007","unstructured":"Helm CW, Toler CR, Martin RS III, Gordinier ME, Parker LP, Metzinger DS, Edwards RP. Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity. Int J Gynecol Cancer. 2007;17:204\u20139.","journal-title":"Int J Gynecol Cancer."},{"key":"6307_CR17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/IGC.0b013e3181a83f7e","volume":"20","author":"N Bakrin","year":"2010","unstructured":"Bakrin N, Cotte E, Sayag-Beaujard A, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of recurrent endometrial carcinoma confined to the peritoneal cavity. Int J Gynecol Cancer. 2010;20:809\u201314.","journal-title":"Int J Gynecol Cancer."},{"key":"6307_CR18","first-page":"1041","volume":"33","author":"DA Santeufemia","year":"2013","unstructured":"Santeufemia DA, Lumachi F, Basso SM, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy as salvage treatment for a late wound recurrence of endometrial cancer. Anticancer Res. 2013;33:1041\u20134.","journal-title":"Anticancer Res."},{"key":"6307_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejogrb.2013.10.026","volume":"172","author":"J Delotte","year":"2014","unstructured":"Delotte J, Desantis M, Frigenza M, Quaranta D, Bongain A, Benchimol D, Bereder JM. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of endometrial cancer with peritoneal carcinomatosis. Eur J Obstet Gynecol Reprod Biol. 2014;172:111\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"6307_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5144\/0256-4947.2014.159","volume":"34","author":"A Abu-Zaid","year":"2014","unstructured":"Abu-Zaid A, Azzam AZ, AlOmar O, Salem H, Amin T, Al-Badawi IA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases. Ann Saudi Med. 2014;34:159\u201366.","journal-title":"Ann Saudi Med."},{"key":"6307_CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014;133:401\u20134.","journal-title":"Gynecol Oncol."},{"key":"6307_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"key":"6307_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"6307_CR24","unstructured":"Common terminology criteria for adverse events (CTCAE) Version 4.0. National Cancer Institute, 2009."},{"key":"6307_CR25","volume-title":"Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas","author":"PH Sugarbaker","year":"2013","unstructured":"Sugarbaker PH. Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas. Cine-Med Publishing Inc., Woodbury; 2013."},{"key":"6307_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/107327480901600104","volume":"16","author":"PJ Frederick","year":"2009","unstructured":"Frederick PJ, Straughn JM Jr. The role of comprehensive surgical staging in patients with endometrial cancer. Cancer Control. 2009;16:23\u20139.","journal-title":"Cancer Control."},{"key":"6307_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","volume":"113","author":"A Giorgio Di","year":"2008","unstructured":"Di Giorgio A, Naticchioni E, Biacchi D, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 2008;113:315\u201325.","journal-title":"Cancer."},{"issue":"Suppl 2","key":"6307_CR28","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0020-7292(12)60024-1","volume":"119","author":"F Amant","year":"2012","unstructured":"Amant F, Mirza MR, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2012;119(Suppl 2):S110\u20137.","journal-title":"Int J Gynaecol Obstet."},{"key":"6307_CR29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/ijc.30537","volume":"140","author":"NL Jones","year":"2017","unstructured":"Jones NL, Xiu J, Chatterjee-Paer S, et al. Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas. Int J Cancer. 2017;140:1396\u2013404.","journal-title":"Int J Cancer."},{"key":"6307_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2012.05.026","volume":"127","author":"KM Esselen","year":"2012","unstructured":"Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S. Patterns of recurrence in advanced epithelial ovarian, fallopian tube, and peritoneal cancers treated with intraperitoneal chemotherapy. Gynecol Oncol. 2012;127:51\u20134.","journal-title":"Gynecol Oncol."},{"key":"6307_CR31","unstructured":"European Medicines Agency. Guideline on the evaluation of anticancer medical products in man (13 December 2012). http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/01\/WC500137128.pdf. Accessed 31 Oct 2014."},{"key":"6307_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol."},{"key":"6307_CR33","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","volume":"113","author":"G Passot","year":"2016","unstructured":"Passot G, Vaudoyer D, Villeneuve L, et al. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1125 procedures. J Surg Oncol. 2016;113:796\u2013803.","journal-title":"J Surg Oncol."},{"key":"6307_CR34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution\u2019s experience during two decades. Ann Surg Oncol. 2017;24:898\u2013905.","journal-title":"Ann Surg Oncol."},{"key":"6307_CR35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol."},{"key":"6307_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2010.04.005","volume":"118","author":"JN Barlin","year":"2010","unstructured":"Barlin JN, Puri I, Bristow RE. Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol. 2010;118:14\u20138.","journal-title":"Gynecol Oncol."},{"key":"6307_CR37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2011.05.020","volume":"122","author":"KK Shih","year":"2011","unstructured":"Shih KK, Yun E, Gardner GJ, Barakat RR, Chi DS, Leitao MM Jr. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol. 2011;122:608\u201311.","journal-title":"Gynecol Oncol."},{"key":"6307_CR38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2407-14-135","volume":"14","author":"Y Ren","year":"2014","unstructured":"Ren Y, Shan B, Shi D, Wang H. Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study. BMC Cancer. 2014;14:135.","journal-title":"BMC Cancer."},{"key":"6307_CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","volume":"134","author":"WM Burke","year":"2014","unstructured":"Burke WM, Orr J, Leitao M, et al. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014;134:385\u201392.","journal-title":"Gynecol Oncol."},{"key":"6307_CR40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","volume":"134","author":"WM Burke","year":"2014","unstructured":"Burke WM, Orr J, Leitao M, et al. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol. 2014;134:393\u2013402.","journal-title":"Gynecol Oncol."},{"key":"6307_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijsu.2015.01.001","volume":"14","author":"I Alagkiozidis","year":"2015","unstructured":"Alagkiozidis I, Grossman A, Tang NZ, et al. Survival impact of cytoreduction to microscopic disease for advanced-stage cancer of the uterine corpus: a retrospective cohort study. Int J Surg. 2015;14:61\u20136.","journal-title":"Int J Surg."},{"key":"6307_CR42","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1245\/s10434-015-4504-5","volume":"22","author":"A Papadia","year":"2015","unstructured":"Papadia A, Bellati F, Ditto A, et al. Surgical treatment of recurrent endometrial cancer: time for a paradigm shift. Ann Surg Oncol. 2015;22:4204\u201310.","journal-title":"Ann Surg Oncol."},{"key":"6307_CR43","doi-asserted-by":"crossref","unstructured":"Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26:2\u201330.","DOI":"10.1097\/IGC.0000000000000609"},{"key":"6307_CR44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2016.02.002","volume":"141","author":"MQ Bernardini","year":"2016","unstructured":"Bernardini MQ, Gien LT, Lau S, et al. Treatment-related outcomes in high-risk endometrial carcinoma: Canadian high-risk endometrial cancer consortium (CHREC). Gynecol Oncol. 2016;141:148\u201354.","journal-title":"Gynecol Oncol."},{"key":"6307_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2008.10.009","volume":"112","author":"LM Landrum","year":"2009","unstructured":"Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Gynecol Oncol. 2009;112:337\u201341.","journal-title":"Gynecol Oncol."},{"key":"6307_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.04.018","volume":"146","author":"LL Holman","year":"2017","unstructured":"Holman LL, Pal N, Iglesias DA, et al. Factors prognostic of survival in advanced-stage uterine serous carcinoma. Gynecol Oncol. 2017;146:27\u201333.","journal-title":"Gynecol Oncol."},{"key":"6307_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00404-015-3841-8","volume":"293","author":"A Rabinovich","year":"2016","unstructured":"Rabinovich A. Neo-adjuvant chemotherapy for advanced-stage endometrial carcinoma: a glimmer of hope in select patients. Arch Gynecol Obstet. 2016;293:47\u201353.","journal-title":"Arch Gynecol Obstet."},{"key":"6307_CR48","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","volume":"22","author":"E Stelloo","year":"2016","unstructured":"Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC Cohorts. Clin Cancer Res. 2016;22:4215\u201324.","journal-title":"Clin Cancer Res."},{"key":"6307_CR49","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3892\/ol.2017.6640","volume":"14","author":"H Kunitomi","year":"2017","unstructured":"Kunitomi H, Banno K, Yanokura M, et al. New use of microsatellite instability analysis in endometrial cancer. Oncol Lett. 2017;14:3297\u2013301.","journal-title":"Oncol Lett."},{"key":"6307_CR50","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","volume":"24","author":"A Giorgio Di","year":"2017","unstructured":"Di Giorgio A, De Iaco P, De Simone M, et al. Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective italian multicenter observational study of 511 cases. Ann Surg Oncol. 2017;24:914\u201322.","journal-title":"Ann Surg Oncol."},{"key":"6307_CR51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2015.09.001","volume":"139","author":"AD Altman","year":"2015","unstructured":"Altman AD, Ferguson SE, Atenafu EG, et al. Canadian high-risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers. Gynecol Oncol. 2015;139:268\u201374.","journal-title":"Gynecol Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-6307-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6307-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6307-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T17:04:22Z","timestamp":1518627862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-6307-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["6307"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-6307-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]}}}